A Cambridge-developed AI vaccine targeting shared features across coronavirus families has passed a phase I safety trial, with a phase II study now planned.
Press Association
Source link : https://www.medscape.com/s/viewarticle/cambridge-teams-ai-vaccine-passes-first-human-trial-2026a1000iyl?src=rss
Author :
Publish date : 2026-06-07 09:05:00
Copyright for syndicated content belongs to the linked Source.